| Osaterone acetate |  Last updated: 16/09/2025 |  | (Also known as: OA; TZP-4238) | 
| 
 |   | 
| 
 | A synthetic steroid that is a hormone chemically related to progesterone, and as such, it has anti-androgen and progestagen activity | |
|---|---|---|
| 
 | Used in the treatment of benign prostatic hyperplasia (BPH) in male dogs | |
| 
 | Dogs | 
| Approval status | 
| 
 | Approved - usually available as a prescription only medicine to be authorised by a veterinarian (POM-V) | |
|---|---|---|
| 
 | Approved | 
| Chemical structure | 
| 
 | None | |
|---|---|---|
| 
 | C₂₂H₂₇ClO₅ | |
| 
 | CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)OCC34C)Cl)C)OC(=O)C | |
| 
 | CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)OC[C@]34C)Cl)C)OC(=O)C | |
| 
 | KKTIOMQDFOYCEN-OFUYBIASSA-N | |
| 
 | InChI=1S/C22H27ClO5/c1-12(24)22(28-13(2)25)8-6-16-14-9-18(23)17-10-19(26)27-11-20(17,3)15(14)5-7-21(16,22)4/h9-10,14-16H,5-8,11H2,1-4H3/t14-,15+,16+,20-,21+,22+/m1/s1 | |
| 
 | Yes | 
| General status | 
| 
 | Steroid | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | Unclassified substance | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | Synthetic | ||||||||||||||
| 
 | A steroidal androgen antagonist which inhibits the effects of an excess production of testosterone | ||||||||||||||
| 
 | [Testosterone, Inhibitor] | ||||||||||||||
| 
 | 105149-00-6 | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | Genito urinary system & sex hormones: Urologicals | ||||||||||||||
| 
 | QG04CX90 | ||||||||||||||
| 
 | No | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | 406.90 | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | 17α-acetoxy-6-chloro-2-oxa-4,6-pregnadiene-3,20-dione | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | 
 | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| 
 | - | ||||||||||||||
| Commercial | 
| 
 | 
 | |||
|---|---|---|---|---|
| 
 | Current | |||
| 
 | Circa 1985, first synthesis & charcaterisation; 2007, intoduced to veterinary market | |||
| 
 | 
 | |||
| 
 | 
 | |||
| 
 | Usually supplied in tablet form for oral administration | |||
| 
 | The synthesis of osaterone acetate involves a multi-step transformation of a progesterone-like steroid nucleus. The process begins with the chemical modification of the steroid backbone, typically derived from pregnenolone or similar intermediates, through selective oxidation and functional group manipulation to introduce a ketone at the C3 position and a double bond in the A-ring. A crucial step is the acetylation at the 17alpha-hydroxy position, forming the acetate ester that enhances oral bioavailability. | |||
| 
 | Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. | 
| 
 |   | 
| 
 | 
 | 
 | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | 253 | L3 L = Pesticide manuals and hard copy reference books / other sources 3 = Unverified data of known source | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| - | |||||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | ||||||||||
| Degradation | 
| 
 | 
 | 
 | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | ||||||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | ||||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | ||||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
| 
 | - | ||||||||||
| Soil adsorption and mobility | 
| 
 | 
 | 
 | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | 
 | - | - | - | |||||||
| 
 | - | ||||||||||
| 
 | - | ||||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | ||||||||||
| 
 | - | ||||||||||
| 
 | - | ||||||||||
| 
 | - | ||||||||||
| Fate indices | 
| 
 | 
 | 
 | 
 | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | - | - | - | ||||||||||||||||||||||||||
| 
 | 
 | - | - | - | |||||||||||||||||||||||||
| 
 | - | - | |||||||||||||||||||||||||||
| Known soil and groundwater metabolites | 
None
| Other known metabolites | 
| 
 | 
 | 
 | 
 | ||||
|---|---|---|---|---|---|---|---|
| 15beta-hydroxylated osaterone acetate Note: Pharmacologically active | - | - | - | ||||
| 17alpha-acetoxy-6-chloro-15beta-hydroxy-2-oxa-4,6-pregnadiene-3,20-dione | 15beta-OH OA | Rats; Mice | - | ||||
| 17alpha-acetoxy-6-chloro-11beta-hydroxy-2-oxa-4,6-pregnadiene-3,20-dione | 11beta-OH OA | Rats; Mice | - | 
| 
 |   | 
| Terrestrial ecotoxicology | 
| 
 | 
 | 
 | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | > 2000 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID )Rat 3 = Unverified data of known source | Low | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | |||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | ||||||||||
| 
 | 
 | - | - | - | |||||||
| - | |||||||||||
| 
 | - | - | - | ||||||||
| - | |||||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | ||||||||||
| 
 | 
 | - | - | - | |||||||
| 
 | - | ||||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| Aquatic ecotoxicology | 
| 
 | 
 | 
 | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | - | - | 
 | - | - | - | |||
| 
 | - | - | - | ||||||||
| 
 |   | 
| General | 
| 
 | 
 | 
 | 
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | High (class III) | - | - | ||||||||
| 
 | > 2000 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID )Rat 3 = Unverified data of known source | Low | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | Subcutaneous LD₅₀ > 2000 mg kg⁻¹ | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID )Rat 3 = Unverified data of known source | - | ||||||||
| Intraperitoneal LD₅₀ = 557 mg kg⁻¹ | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID )Rat 3 = Unverified data of known source | - | |||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | - | - | - | ||||||||
| 
 | 
 | - | |||||||||
| 
 | - | ||||||||||
| 
 | Excreted primarily in faeces (~60%) and the remainder in the urine | A5 A = EU regulatory and evaluation data as published by EC, EFSA (RAR, DAR & Conclusion dossiers), EMA (e.g. EU Annex III PIC DGD) (EU - Pesticides database; EFSA Scientific Publications ) 5 = Verified data used for regulatory purposes | - | ||||||||
| Health issues | 
| 
 | 
 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | Possible kidney and bladder toxicant | ||||||||||||||||||||||||||||
| Handling issues | 
| 
 | 
 | |||
|---|---|---|---|---|
| 
 | No information available | |||
| 
 | - | |||
| 
 | Not listed (Not listed) | |||
| 
 | - | |||
| 
 | - | |||
| 
 | - | 
| 
 |   | 
| 
 | 
 | ||
|---|---|---|---|
| 
 | osaterone acetate | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | ||
| 
 | - | 
| Record last updated: | 16/09/2025 | 
| Contact: | aeru@herts.ac.uk | 
| Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 | 


